The research peptide market spans the spectrum from well-documented analytical suppliers to vendors that ship unmarked vials with no certification. For investigators sourcing peptides, vendor selection is itself part of the experimental design — a reagent from a poorly-documented source introduces an unverifiable variable that affects every result derived from it.
A Certificate of Analysis (COA) is the document that links a specific lot of research-grade peptide to the analytical data establishing its identity, purity, and physicochemical characteristics. For investigators sourcing peptides for preclinical work, the COA is the primary instrument of supplier verification — it converts a manufacturer’s claims into measurable, reproducible data.
Reading peptide research papers critically is the single highest-leverage skill in this field. The published literature on individual compounds spans a wide range of evidence quality — from small uncontrolled in vitro experiments through large pivotal Phase 3 randomized trials — and the strength of any conclusion drawn from a paper is bounded by the design…
